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Recently in Nature, Sun et al. (2014) used a sleeping beauty transposon system to demonstrate that natural
hematopoiesis is sustained by the successive recruitment of thousands of clones that are mostly lineage
restricted. These findings call into question whether homeostatic hematopoiesis is sustained by hematopoi-
etic stem cells traditionally identified by transplantation.Traditionally, hematopoietic stem cells
(HSCs) have been identified as cells
that can perpetually regenerate all blood
cell types in a myeloablated recipient.
They are very rare and mostly quiescent
(Seita and Weissman, 2010). Two gen-
eral models have been put forth for
how HSCs are recruited into differentia-
tion under normal physiological condi-
tions. The ‘‘clonal succession model’’
proposes that small numbers of HSCs
are sequentially recruited to enter the
cell cycle and thereby initiate the line-
age commitment process (Jordan and
Lemischka, 1990; Lemischka et al.,
1986). Upon the exhaustion of their pro-
ductive life spans, they are succeeded
by a different group of HSCs. In contrast,
the ‘‘clonal stability model’’ suggests
that a single, static group of HSCs
continuously replenishes blood cells
throughout an organism’s lifetime (Abko-
witz et al., 1995; McKenzie et al., 2006;
Prchal et al., 1996). Previous efforts to
discriminate between these two models
relied on transplantation experiments. It
was observed that after a short period
of clonal fluctuation following transplan-
tation, a few HSC clones stably supply
blood throughout the recipient’s life
span (Abkowitz et al., 1995; McKenzie
et al., 2006; Prchal et al., 1996).
In these transplantation studies, indi-
vidual HSCs were tracked using viral
infection applied ex vivo prior to trans-
plantation. This approach is not feasible
for labeling HSCs in vivo because HSCs
are dispersed in bone marrow throughout
the body. It is also difficult to employ
fluorescent proteins for clonal tracking, alabeling strategy widely used in solid tis-
sues, because HSCs migrate and their
progeny blood cells circulate.
To conquer these technical challenges,
the Camargo group adopted a creative
approach to track cells using a trans-
poson system cloned into mice (Sun
et al., 2014). The transposon is activated
by a hyperactive ‘‘sleeping beauty’’ trans-
posase whose expression is controlled by
doxycycline. During the short time period
when doxycycline is applied to a mouse,
the transposon can randomly mobilize to
a different genomic location. This trans-
position creates an inheritable genomic
DNA insertion that is unique to individual
cells and their progenies. Cells originating
from a common ancestor can be identi-
fied by their common transposon inser-
tion site. The authors have conducted a
series of experiments to demonstrate
the fidelity and sensitivity of this experi-
mental system.
This transposon-based cellular tracking
system provides an exciting opportunity
to study native hematopoiesis without
the use of transplantation. Moreover, the
Camargo group used a universal pro-
moter that marks all cells randomly and
thereby provides an unbiased method
to identify cells that sustain the blood
supply. In contrast, transplantation exper-
iments can only track cells that engraft.
Engrafted cells may proliferate, and con-
sequently multiple HSCs may share the
same marker. This may be partially
responsible for the previously observed
clonal stability.
Indeed, the transposon system has
produced strikingly different results fromCell Stem Cell 15,previous studies. At each of their
measured time points, dramatically
different clones appear to supply the
blood. This phenomenon persists even
after 4 months postlabeling when blood
is thought to derive only from HSCs.
The authors also used single-cell assays
to confirm the fast clonal turnover and
they estimated that thousands of clones
contribute to blood formation at any time
point. Thus, their data suggest that long-
term hematopoiesis is sustained by the
successive recruitment of a large number
of clones. While their observed clonal
dynamics are consistent with the ‘‘clonal
successionmodel,’’ their estimated clonal
complexity is much greater than what
could possibly be supported by the small
number of HSCs traditionally identified
using transplantation methods.
This finding raises some key questions:
what cells can account for the observed
clonal abundances and sustain the long-
term blood supply? Are ‘‘traditional’’
HSCs involved at all with homeostatic
hematopoiesis? To address these ques-
tions, the authors performed two ex-
periments. First, they compared the
clonal composition of hematopoietic cells
from clonally marked donor mice with
that from transplanted recipient mice.
They found that donor and recipient
mice possessed different clonal reper-
toires. Second, they compared the clonal
composition of HSCs, intermediate pro-
genitors, and mature cells from a single
mouse. They found that fewer than
5% of HSC clones are subsequently rep-
resented in mature cell populations,
whereas approximately half of theDecember 4, 2014 ª2014 Elsevier Inc. 677
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Previewsmultipotent progenitor (MPP) andmyeloid
progenitor (MyP) clones contribute to
mature cell populations. Based on these
two experiments, the authors conclude
that the cells that supply blood under
homeostatic conditions are not trans-
plantable and are not found in the conven-
tionally defined HSC pool. Moreover, they
suggest that the large number of progen-
itor cells, including previously defined
MPPs and MyPs, may be the major
source of ongoing hematopoiesis. These
data do not exclude the possibility that
HSCs participate in steady-state blood
production, but if they do, they must be
quickly depleted from the HSC pool
once they have committed to differentia-
tion (known as the ‘‘successive deletion’’
model). It will be interesting to examine
in future studies whether the number of
HSC clones shrinks over time.
The Camargo group also examined
another defining characteristic of HSCs,
multipotency, by comparing the clonality
of distinct differentiated cell types in
bone marrow with similar maturation
times. They found that around half of the
lymphoid cell clones are also present in
myeloid cells 10 months after single-cell
marking is initiated, indicating the active
production of diverse lineages bymultipo-
tent stem or progenitor cells. However,
most of the myeloid clones are myeloid
restricted throughout the observation
period for up to 45 weeks. This suggests
that lineage-restricted progenitors can
also supply blood over the long term,
which further challenges the conventional
view of how HSCs supply blood under
normal physiological conditions.
Transplantation allows the study of
cells isolated by a combination of678 Cell Stem Cell 15, December 4, 2014 ª2markers. It requires the removal of the re-
cipient’s blood system so that donor he-
matopoietic cells can engraft. This injury
and repair process may involve different
stem and progenitor cells from those
that maintain homeostatic blood supply.
Recent studies of hair follicle stem cells
and intestinal stem cells suggest that tis-
sue repair and homeostasis may be sus-
tained by distinct stem and progenitor
cells and through different mechanisms
(Ito et al., 2005; Tian et al., 2011). In their
paper, the Camargo group demonstrated
for the first time that different stem and
progenitor cells sustain and repair the
hematopoietic system. If stem cells
are defined as cells with the potential
for self-renewal and differentiation, then
traditionally identified HSCs are un-
doubtedly qualified to be called stem
cells. However, since engraftment is not
a required capacity of stem cells by defi-
nition, perhaps our previously identified
HSCs are only a small subset of all
stem cells in the blood system. Nonethe-
less, those traditional stem cells possess
the capacity for engraftment and long-
term blood reconstitution and are there-
fore the only cells accessible for bone
marrow transplantation therapy.
The striking clonal dynamics discov-
ered by the Camargo group reveal
new regulatory mechanisms unobtain-
able from population level studies. A
similar long-term clonal turnover in blood
has recently been reported in nonhuman
primates (Kim et al., 2014). These
exciting findings bring forth many new
questions. For instance, the identities of
the cells that sustain homeostatic hema-
topoiesis remain to be elucidated, and
the underlying regulatory systems are014 Elsevier Inc.unknown as well. The dynamic clonal
turnover discovered in the study by the
Camargo group provides a new basis
for studying development and aging of
natural hematopoiesis. Future studies
need to look beyond traditional HSCs
for target cells where oncogenic muta-
tions may arise and accumulate over
time. More clonal-level analyses are on
their way to resolve these questions
and together they may radically change
our perspective of hematopoiesis.
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